Inhibition of cell proliferation and migration by oxidative stress from ascorbate-driven juglone redox cycling in human bladder-derived T24 cells

Biochemical and Biophysical Research Communications

Volumn 421, Issue 2, 2012, Pages 268-273

  Kviecinski, M R ^a   Pedrosa, R C ^a   Felipe, K B ^a   Farias, M S ^a   Glorieux, C ^b   Valenzuela, M ^b   Sid, B ^b   Benites, J ^c   Valderrama, J A ^c,d   Verrax, J ^b   Buc Calderon, P ^b,c  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSIDAD ARTURO PRAT   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Ascorbate; Cell migration; Juglone; Proliferation; Redox impairment; T24 cells

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; BETA ACTIN; CASPASE 3; CATALASE; GLUTATHIONE; HISTONE H2AX; INITIATION FACTOR 2ALPHA; JUGLONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CELL KILLING; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE;

ANTINEOPLASTIC AGENTS; ASCORBIC ACID; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; NAPHTHOQUINONES; OXIDATION-REDUCTION; OXIDATIVE STRESS; URINARY BLADDER;

EID: 84860469507     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.150     Document Type: Article

References (35)

1. Aithal B.K., Sunil Kumar M.R., Nageshwar Rao B., Udupa N., Satish Rao B.S. Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells. Cell. Biol. Int. 2009, 33:1039-1049.
2. Babula P., Adam V., Kizek R., Sladky Z., Havel L. Naphthoquinones as allelochemical triggers of programmed cell death. Environ. Exper. Bot. 2009, 65:330-337.
3. Babich H., Stern A. In Vitro Cytotoxicities of 1,4-naphthoquinone and hydroxylated 1,4-naphthoquinones to replicating cells. J. Appl. Toxicol. 1993, 13:353-358.
4. Bonifazi E.L., Ríos-Luci C., León L.G., Burton G., Padrón J.M., Misico R.I. Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol. Bioorg. Med. Chem. 2010, 18:2621-2630.
5. Montenegro R.C., Araújo A.J., Molinab M.T., Marinho Filho J.D.B., Rocha D.D., López-Montero E., Goulart M.O.F., Bento E.S., Alves A.P.N.N., Pessoa C., de Moraes M.O., Costa-Lotufo L.V. Cytotoxic activity of naphthoquinones with special emphasis on juglone and its 5-o-methyl derivative. Chem. Biol. Interact. 2010, 184:439-448.
6. K.B. Aithal, S. Kumar, B.N. Rao, N. Udupa, S.B. Rao, Tumor growth inhibitory effect of juglone and its radiation sensitizing potential: in vivo and in vitro studies, Integr. Cancer. Ther., 2011.
7. Ji Y.B., Qu Z.Y., Zou X. Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. Exp. Toxicol. Pathol. 2011, 63:69-78.
8. Xu H.L., Yu X.F., Qu S.C., Zhang R., Qu X.R., Chen Y.P., Ma X.Y., Sui D.Y. Anti-proliferative effect of juglone from Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing apoptosis through the mitochondria-depent pathway. Eur. J. Pharmacol. 2010, 645:14-22.
9. X. Zou, Y.B. Ji, S.Y. Gao, Effect of juglone in Qinglongyi on cell cycle status and apoptosis in A-549 cells, International Conference on Environmental Science and Information Application Technology (ESIAT) (2010) 736-738.
10. Trachootham D., Zhou Y., Zhang H., Demizu Y., Chen Z., Pelicano H., Chiao P., Achanta G., Arlinghaus R., Liu J., Huang P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 2006, 10:241-252.
11. Verrax J., Beck R., Dejeans N., Glorieux C., Sid D., Pedrosa R.C., Benites J., Vásquez D., Valderrama J.A., Buc Calderon P. Redox-active quinones and ascorbate: an innovative cancer therapy that exploits the vulnerability of cancer cells to oxidative stress. Anticancer Agents Med. Chem. 2011, 11:213-221.
12. Verrax J., Stockis J., Tison A., Taper H., Buc Calderon P. Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukemia cells and inhibits its tumor growth in nude mice. Biochem. Pharmacol. 2006, 72:671-680.
13. Verrax J., Delvaux M., Beghein N., Taper H., Gallez B., Buc Calderon P. Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells: an in vitro comparative study. Free. Radic. Res. 2005, 39:649-657.
14. Benites J., Rojo L., Valderrama J.A., Taper H., Buc Calderon P. Part 1: effect of vitamin C on the biological activity of two eurofurylbenzoquinones on TLT, a murine hepatoma cell line. Eur. J. Med. Chem. 2008, 43:1813-1817.
15. Vásquez D.R., Verrax J., Valderrama J.A., Buc Calderon P. Aminopyrimidoisoquinolinequinone (APIQ) redox cycling is potentiated by ascorbate and induces oxidative stress leading to necrotic-like cancer cell death. Invest. New Drugs 2011, 10.1007/s10637-011-9661-1.
16. Agus D.B., Vera J.C., Golde D.W. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res. 1999, 59:4555-4558.
17. Verrax J., Pedrosa R.C., Dejeans N., Taper H.S., Calderón P.B. In situ modulation of oxidative stress: a novel and efficient strategy to kill cancer cells. Curr. Med. Chem. 2009, 16:1821-1830.
18. Öllinger K., Brunmark A. Effect of hydroxy substituent position on 1,4-naphthoquinone toxicity to rat hepatocytes. J. Biol. Chem. 1991, 266:21496-21503.
19. Oelgemöller M., Healy N., de Oliveira L., Jung C., Mattay J. Green photochemistry: solar-chemical synthesis of juglone with medium concentrated sunlight. Green Chem. 2006, 8:831-834.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
21. Glorieux C., Dejeans N., Sid B., Beck R., Buc Calderon P., Verrax J. Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem. Pharmacol. 2011, 15:1384-1390.
22. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 1980, 106:207-212.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:268-275.
24. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnick Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 2002, 376:37-43.
25. Adhami V.M., Aziz M.H., Mukhtar H., Ahmad N. Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin. Cancer Res. 2003, 1(9):3176-3182.
26. Franken N.A.P., Rodermond H.M., Stap J., Haveman J., van BREE C. Clonogenic assay of cells in vitro. Nat. Protocol. 2006, 1:2315-2319.
27. Weiss R.B. The anthracyclines: will we ever find a better doxorubicin?. Semin. Oncol. 1992, 19:670-686.
28. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 2004, 56:185-229.
29. Joyce N.C., Zhu C.C., Harris D.L. Relationship among oxidative stress, DNA damage, and proliferative capacity in human corneal endothelium. Invest. Ophthalmol. Vis. Sci. 2009, 50:2116-2122.
30. Yuan J., Adamski R., Chen J. Focus on histone variant H2AX: to be or not to be. FEBS Lett. 2010, 584:3717-3724.
31. Paulsen M.T., Ljungman M. The natural toxin juglone causes degradation of p53 and induce rapid H2AX phosphorilation and cell death in human fibroblast. Toxicol. Appl. Pharmacol. 2005, 209:1-9.
32. Dejeans N., Tajeddine N., Beck R., Verrax J., Taper H., Gailly P., Calderon P.B. Endoplasmic reticulum calcium release potentiates the ER stress and cell death caused by an oxidative stress in MCF-7 cells. Biochem. Pharmacol. 2010, 79:1221-1230.
33. Fila C., Metz C., Van der Sluijs P. Juglone inactivates cysteine-rich proteins required for progression through mitosis. J. Biol. Chem. 2008, 283:21714-21724.
34. Sahai E. Mechanisms of cancer invasion. Curr. Opin. Genet. Dev. 2005, 15:87-96.
35. Kohn E.C., Liotta L.A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 1995, 55:1856-1862.